serena williams glp 1 commercial Tennis legend is making headlines after her Super Bowl ad promoting GLP-1 weight-loss medication went viral. The retired star revealed she lost around 14 kg with Zepbound through telehealth company Serena Williams on Why She

FDA advisers back first four of seven unapproved peptides under review for looser rules

Because of these risks, PT-141 should only be used under medical supervision

WHO Adds Popular Weight-Loss Drugs to Essential Medicines List The World Health Organization (WHO) has officially added GLP-1 receptor agonist drugs, including Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro), to its Essential Medicines List

Association between serum uric acid, hyperuricemia and periodontitis: a cross-sectional study using NHANES data

Rabbit anti-PKA C, anti-phospho-Thr197-PKA C (p-PKA), anti-AMPK and anti-phospho-Thr-172-AMPK (p-AMPK) antibodies were obtained from Cell Signalling Technology

The interest of the scientific community in IGF-1 LR3 peptide is continuously growing due to research conducted in growth factor signaling